Targeting SNRPE to Induce Pyroptosis Enhances Antitumor Immunity in Breast Cancer.

Zaixiong Ji, Zilin Wang, Xinyu Guo, Junjian Li, Yiran Cai, Kangan Li

Abstract read

In one paragraph

Article in International journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Spliceosomal component SNRPE drives cell proliferation by regulating CTP synthase 1 mRNA splicing in ovarian cancer.Oncogene · 2026
Article
Integrative multi-omics analysis identifies SNRPE as a key driver gene in uterine corpus endometrial carcinoma: promoting tumor progression, and mediating immune evasion.Frontiers in immunology · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zaixiong JiDepartment of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, P. R. China.

Zilin WangMini-invasive Interventional Therapy Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, P.R. China.

Xinyu GuoMini-invasive Interventional Therapy Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, P.R. China.

Junjian LiState Key Laboratory of Systems Medicine for Cancer, Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, P. R. China.

Yiran CaiDepartment of Pathology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, P. R. China.

Kangan LiMini-invasive Interventional Therapy Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsPyroptosisAnimalsCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansKiller Cells, NaturalMicePrognosisSpliceosomesTumor MicroenvironmentXenograft Model Antitumor Assaysantitumor immunitybreast cancerprognosispyroptosisSNRPEspliceosome

Identifiers

PMID40386046

DOI10.7150/ijms.109171

PMCPMC12080576

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.